![Axonics 1101 Скачать руководство пользователя страница 6](http://html.mh-extra.com/html/axonics/1101/1101_manual_3040483006.webp)
6
INTRODUCTION
This manual provides information about the Axonics Sacral Neuromodulation (SNM) System Neurostimulator (Model 1101), which is a part of the Axonics SNM System.The Neurostimulator
is connected to the Axonics tined lead (Model 1201 or 2201).
AXONICS SNM THERAPY FOR URINARY CONTROL
Indications
Axonics SNM therapy for urinary control is indicated for the treatment of urinary retention and the symptoms of overactive bladder, including urinary urge incontinence and significant
symptoms of urgency-frequency alone or in combination, in patients who have failed or could not tolerate more conservative treatments.
Warning:
This therapy is not intended for patients with mechanical obstruction such as benign prostatic hypertrophy, cancer, or urethral stricture.
Precautions
Clinician training
Implanting clinicians
should be trained on the implantation and use of the Axonics SNM System.
Prescribing clinicians
should be experienced in the diagnosis and treatment of lower urinary tract symptoms and should be trained on the use of the Axonics SNM System.
Use in specific populations
The safety and effectiveness of this therapy has not been established for:
• Pregnant women
• Pediatric use (patients under the age of 16)
• Patients with neurological disease origins, such as multiple sclerosis or diabetes
• Bilateral stimulation.
AXONICS SNM THERAPY FOR BOWEL CONTROL
Indications
Axonics SNM therapy for bowel control is indicated for the treatment of chronic fecal incontinence in patients who have failed or are not candidates for more conservative treatments.
Precautions
Clinician training
Implanting clinicians
should be trained on the implantation and use of the Axonics SNM System.
Prescribing clinicians
should be experienced in the diagnosis and treatment of fecal incontinence and should be trained on the use of the Axonics SNM System.
Use in specific populations
The safety and effectiveness of this therapy has not been established for:
• Pregnant women
• Pediatric use (patients under the age of 18)
• Patients with progressive, systemic neurological diseases
• Bilateral stimulation.
CONTRAINDICATIONS
The Axonics SNM System is contraindicated for patients who are unable to operate the Axonics SNM System.
WARNINGS
Diathermy
Shortwave diathermy, microwave diathermy, or therapeutic ultrasound diathermy (collectively described as diathermy) should not be used on patients implanted with the Axonics SNM
System. Diathermy can transmit energy through the implanted system, potentially causing tissue damage at the location of the implanted electrodes, resulting in severe injury.
Magnetic Resonance Imaging (MRI)
The Axonics SNM System is an MRI Conditional system. Refer to“MRI Guidelines for the Axonics Sacral Neuromodulation System” for more information.
Axonics 110-0003 rev M_output.indd 6
9/25/18 7:49 AM
Содержание 1101
Страница 2: ...2 Axonics 110 0003 rev M_output indd 2 9 25 18 7 49 AM ...
Страница 4: ...4 Axonics 110 0003 rev M_output indd 4 9 25 18 7 49 AM ...
Страница 18: ...18 Axonics 110 0003 rev M_output indd 18 9 25 18 7 49 AM ...
Страница 34: ...34 Axonics 110 0003 rev M_output indd 34 9 25 18 7 49 AM ...
Страница 48: ...48 Axonics 110 0003 rev M_output indd 48 9 25 18 7 49 AM ...
Страница 50: ...50 Axonics 110 0003 rev M_output indd 50 9 25 18 7 49 AM ...
Страница 64: ...64 Axonics 110 0003 rev M_output indd 64 9 25 18 7 49 AM ...
Страница 66: ...66 Axonics 110 0003 rev M_output indd 66 9 25 18 7 49 AM ...
Страница 80: ...80 Axonics 110 0003 rev M_output indd 80 9 25 18 7 49 AM ...
Страница 82: ...82 Axonics 110 0003 rev M_output indd 82 9 25 18 7 49 AM ...